COVID19 update page

This page lists articles and resources regarding COVID19 information for BOPSS members. BOPSS 2020 Meeting is postponed COVID19 News articles on Situation regarding Covid-19 for BOPSS 2021 meeting March 16, 2020 January 22, 2021Electrocautery as an Aerosol generating Procedure June 4, 2020 June 4, 2020Update Guidance on Infection Risk and Personal Protective Equipment (PPE) for Oculoplastic Surgery during the COVID-19 Pandemic April 20, 2020 April 20, 2020TED Immunosuppression advice during Covid-19 April 9, 2020 April 9, 2020COVID-19 [...]

Electrocautery as an Aerosol generating Procedure

Whilst electrocautery is not listed in the widely published lists of AGP, in some experimental models electrocautery has been demonstrated to generate aerosols. In view of this Members should consider employing some form of smoke extraction and wear PPE appropriate for AGP when using electrocautery.   Useful supporting links and documents: Clinical evidence-based review and recommendations of aerosol generating medical procedures in otolaryngology –head and neck surgery during the COVID-19 pandemic Andrew Thamboo1, Jane Lea, Doron D. Sommer, Leigh Sowerby, Arman Abdalkhani, Christopher [...]

Update Guidance on Infection Risk and Personal Protective Equipment (PPE) for Oculoplastic Surgery during the COVID-19 Pandemic

This document is advisory and individual clinicians must assess each case in light of local policy and equipment availability. Only urgent oculoplastic procedures which cannot be delayed should be performed during the current crisis. PPE Recommendations for Oculoplastics Surgery In line with PHE’s advice the following PPE is appropriate in any oculoplastic procedure; Fluid repellent surgical gown Disposable gloves Eye protection and face shield Fluid resistant face mask i.e. a surgical mask (Type IIr)   PPE for High Risk, Aerosol Generating Procedures (AGP) For procedures which [...]

TED Immunosuppression advice during Covid-19

TED Immunosuppression advice during Covid-19 Every TED patient needs to be managed on a case by case basis. These recommendations are not prescriptive but based on collective multidisciplinary experience. Intravenous methyl prednisolone therapy is generally not recommended for treating moderate to severe thyroid eye disease during the COVID19 pandemic. These patients will be at risk of severe suppression of their immune system and it is vital to avoid unnecessary hospital visits for this vulnerable group. Where feasible patients who, under normal circumstances, [...]

COVID-19 Prioritisation

COVID-19 Prioritisation The challenges presented to all ophthalmologists during the COVID-19 pandemic are enormous. Oculoplastic surgeons also face potentially high degrees of viral exposure in clinic and theatre from droplet and aerosol spread. Viral transmission may, or may not, occur from the tears and conjunctiva, but protection of the mouth, nose, and eyes is essential when examining or operating on patients. BOPSS both supports, and have contributed to, the Royal College of Ophthalmologists’ guidelines. We encourage all our members to [...]

Covid-19; high risk patients.

The AoMRC has requested that BOPSS remind members that we may be the primary physician for patients who are at high risk of increased morbidity and mortality from COVID-19  (1). These patients are being asked to consider complete self-isolation – or shielding – for their own safety. A template letter (2) which can be sent to such patients and the information sent out by NHSE (3) is available. Additional information can be found on the AoMRC website (1) AoMRC letter to clinicians (2) [...]